On May 11, 2018 a
Stipulation,Agreement
was filed
involving a dispute between
Cresco Labs Llc, An Illinois Limited Liability Company,
Cresco Labs New York, Llc,
A New York Limited Liability Company,
and
Eric Sirota,
Fiorello Pharmaceuticals, Inc.,
A New York Corporation,
John Does 1 - 10,
Susan Yoss,
for Commercial Division
in the District Court of New York County.
Preview
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF NEW YORK
----------------------------------------------------------- X
CRESCO LABS NEW YORK, LLC, a New :
York limited liability company, and CRESCO : Index No. 652343/2018
LABS LLC, an Illinois limited liability : Hon. Andrew Borrok
company, :
:
Plaintiffs/Counterclaim Defendants, :
:
v. :
:
FIORELLO PHARMACEUTICALS, INC., a :
New York corporation, :
:
Defendant/Counterclaimant :
----------------------------------------------------------- X
SCHEDULING STIPULATION
Cresco Labs New York, LLC, Cresco Labs, LLC (collectively, “Cresco”), and Fiorello
Pharmaceuticals, Inc. (“Fiorello”) hereby stipulate and agree as follows:
1. The dates set in the Court’s January 21, 2022 Decision and Order on motion
sequences 13 and 14 (NYSCEF Doc. No. 677) shall be modified as follows:
a. Cresco shall respond to Fiorello’s demands by February 10;
b. Any additional expert report shall be served and filed by February 22;
2. The dates set forth in the case management order entered by the Court on
November 10, 2021 (NYSCEF Doc. No. 225) shall be further modified as follows:
a. Expert discovery shall conclude by March 30, 2022.
b. Note of issue April 7, 2022.
3. The parties further stipulate and agree that:
a. By February 17, 2022 Cresco shall complete its production of documents
responsive to Fiorello’s January 31 requests.
b. By March 3, Fiorello shall complete the additional deposition(s) agreed
upon by the parties or, if the parties cannot agree, as directed by the Court.
4. Nothing herein is intended to amend or modify the intent of the Court’s January
21, 2022 Order or to grant any party any additional rights.
5. For the purposes of this stipulation, electronic or facsimile signatures shall have
the same force and effect as originals and this stipulation may be executed in one or more
counterparts.
IT IS SO STIPULATED.
By: /s/ Stephen L. Ascher By: /s/ Rachel L. Izower-Fadde
JENNER & BLOCK LLP IZOWER FELDMAN, LLP
Stephen L. Ascher Ronald D. Lefton
Jason P. Hipp Rachel L. Izower-Fadde
Melissa T. Fedornak Arielle Kane
919 Third Avenue 1325 Franklin Avenue, Suite 255
New York, New York 10022 Garden City, NY 11530
212-891-1670 516-231-2260
sascher@jenner.com leftonr@izowerfeldman.com
jhipp@jenner.com rizower@izowerfeldman.com
mfedornak@jenner.com akane@izowerfeldman.com
Counsel for Plaintiffs Cresco Labs New York, Counsel for Defendant Fiorello
LLC and Cresco Labs, LLC Pharmaceuticals, Inc.
Dated: February 3, 2022 Dated: February 3, 2022
2
IT IS SO ORDERED
Dated: __________________________ __________________________________
HONORABLE ANDREW BORROK
3
Document Filed Date
February 03, 2022
Case Filing Date
May 11, 2018
Category
Commercial Division
For full print and download access, please subscribe at https://www.trellis.law/.
Preview
SUPREME COURT OF THE STATE OF NEW YORK COUNTY OF NEW YORK ----------------------------------------------------------- X CRESCO LABS NEW YORK, LLC, a New : York limited liability company, and CRESCO : Index No. 652343/2018 LABS LLC, an Illinois limited liability : Hon. Andrew Borrok company, : : Plaintiffs/Counterclaim Defendants, : : v. : : FIORELLO PHARMACEUTICALS, INC., a : New York corporation, : : Defendant/Counterclaimant : ----------------------------------------------------------- X SCHEDULING STIPULATION Cresco Labs New York, LLC, Cresco Labs, LLC (collectively, “Cresco”), and Fiorello Pharmaceuticals, Inc. (“Fiorello”) hereby stipulate and agree as follows: 1. The dates set in the Court’s January 21, 2022 Decision and Order on motion sequences 13 and 14 (NYSCEF Doc. No. 677) shall be modified as follows: a. Cresco shall respond to Fiorello’s demands by February 10; b. Any additional expert report shall be served and filed by February 22; 2. The dates set forth in the case management order entered by the Court on November 10, 2021 (NYSCEF Doc. No. 225) shall be further modified as follows: a. Expert discovery shall conclude by March 30, 2022. b. Note of issue April 7, 2022. 3. The parties further stipulate and agree that: a. By February 17, 2022 Cresco shall complete its production of documents responsive to Fiorello’s January 31 requests. b. By March 3, Fiorello shall complete the additional deposition(s) agreed upon by the parties or, if the parties cannot agree, as directed by the Court. 4. Nothing herein is intended to amend or modify the intent of the Court’s January 21, 2022 Order or to grant any party any additional rights. 5. For the purposes of this stipulation, electronic or facsimile signatures shall have the same force and effect as originals and this stipulation may be executed in one or more counterparts. IT IS SO STIPULATED. By: /s/ Stephen L. Ascher By: /s/ Rachel L. Izower-Fadde JENNER & BLOCK LLP IZOWER FELDMAN, LLP Stephen L. Ascher Ronald D. Lefton Jason P. Hipp Rachel L. Izower-Fadde Melissa T. Fedornak Arielle Kane 919 Third Avenue 1325 Franklin Avenue, Suite 255 New York, New York 10022 Garden City, NY 11530 212-891-1670 516-231-2260 sascher@jenner.com leftonr@izowerfeldman.com jhipp@jenner.com rizower@izowerfeldman.com mfedornak@jenner.com akane@izowerfeldman.com Counsel for Plaintiffs Cresco Labs New York, Counsel for Defendant Fiorello LLC and Cresco Labs, LLC Pharmaceuticals, Inc. Dated: February 3, 2022 Dated: February 3, 2022 2 IT IS SO ORDERED Dated: __________________________ __________________________________ HONORABLE ANDREW BORROK 3